rss atom
  • Virco Launches Electronic Health Record, AVIGA™ and Data Reporting Module, AVIGA REPORTER™ to HIV Clinics in the United States
    Thursday, 15 December 2011 @ 11:00
    Virco Launches Electronic Health Record and Data Reporting Module Designed Specifically for the HIV/AIDS Treatment Community: AVIGA™and AVIGA REPORTER™     Release of AVIGA™Family of Products Ushers in New Era of HIV Care by Allowing US Health Care Professionals to Manage, Analyze and Act Upon Clinical Data Raritan, US, December 15, 2011: Virco Lab, Inc., the U.S. affiliate of Virco...
  • Virco’s Electronic Health Record AVIGA™ Achieves Major Milestone By Initiating "Meaningful Use" Certification
    Monday, 18 April 2011 @ 14:00
    Raritan, US, April 18, 2011: Virco Lab, Inc., the U.S. affiliate of Virco BVBA, today announced that AVIGA™, an electronic health record (EHR) designed specifically to meet the complex disease-management needs of health care providers who are treating people living with HIV/AIDS, has achieved modular (partial) certification in accordance with the “Meaningful Use Stage 1” requirements in the U.S.  ...
  • virco®TYPE HIV-1 resistance test achieves CE-Marking approval
    Wednesday, 03 November 2010 @ 09:00
      Beerse, Belgium, 3rd November 2010: Virco BVBA has today announced that their HIV resistance testing product, virco®TYPE HIV-1, has achieved CE-Marking approval. virco®TYPE HIV-1 is the only bioinformatic diagnostic device of its kind to carry CE-Marking in the HIV market. The CE-Marking indicates that virco®TYPE HIV-1 is a medical device that complies with all applicable quality and safety standards...
  • Virco's HCV NS5B sequence-based subtyping assay publication
    Monday, 16 August 2010 @ 12:56
      As part of Virco's ongoing support and development of its pharmaceutical research services to the industry, we are pleased to inform you a publication on our hepatitis C subtyping assay (Koletzki D, et al; Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay; Clin Chem and Lab Medicine 2010; 48(8): 1095-1102) is now available for download. Abstract Background: Hepatitis C virus...
  • ABL enters into an international distribution and license agreement for virco®TYPE HIV-1 via TherapyEdge™ EMR
    Tuesday, 13 July 2010 @ 12:49
      Advanced Biologic Laboratories (ABL), a Luxembourg-based global health information technology company dedicated to deliver healthcare products and services to enable its customers to optimize their HIV healthcare services, has signed a non-exclusive international distribution agreement (excluding United States, Australia, Canada and the United Kingdom) to incorporate Virco BVBA's virco®TYPE HIV-1 resistance interpretation system into ABL's electronic medical record and decision support system,...